What Merck Sharp & Dohme LLC pays H-1B Scientist Preclinical Developments

Merck Sharp & Dohme LLC filed 14 certified H-1B LCAs for Scientist Preclinical Development roles in FY2025-FY2026. In FY2026 (October to June), the middle half of its 5 filings stated $117,000 to $117,000 a year, with a median of $117,000.

Median, FY2026 so far$117,000
Middle half$117,000 to $117,000
Certified LCAs, FY2025-FY202614

By fiscal year

YearLCAsMedianMiddle halfLowest to highestPrevailing wage
FY2026 so far5$117,000$117,000 to $117,000$114,700 to $184,200$96,054
FY20259$114,700$114,700 to $114,700$114,700 to $180,500$91,770

Prevailing wage is the median of the DOL prevailing wage on the same filings: the floor the law sets for that job and place.

By prevailing-wage level

LevelLCAsMedianMiddle half
Level I (entry)1$114,700too few
Level II (qualified)9$114,700$114,700 to $114,700
Level III (experienced)3$117,000too few
Level IV (fully competent)1$117,000too few

Level I is entry and Level IV is fully competent, as the employer classified the position. Seniority words in the job title are folded into one title here; the level is where seniority shows.

By worksite

WorksiteLCAsMedianLowest to highest
Rahway, NJ11$114,700$114,700 to $117,000
West Point, PA3$117,000$114,700 to $117,000

Titles grouped here

Filed as Biochemists and Biophysicists (SOC 19-1021).

Applying to Merck Sharp & Dohme LLC?

Nyanza puts these filings next to any Scientist Preclinical Development posting you check, so you know what the employer has stated before the first call.

Other titles at Merck Sharp & Dohme LLC